Characteristics of Patients with Severe Uncontrolled Asthma in Saudi Arabia: A Cross-Sectional Study

This study confirms the substantial burden of severe eosinophilic asthma in the Saudi population, with significant exacerbation rates and healthcare resource use despite conventional therapy. The data suggest a potential role for benralizumab in improving disease outcomes for severe eosinophilic asthma. Further research is needed to evaluate the efficacy and cost-effectiveness of benralizumab in these patients.